Hematological Disorders

A biosimilar (copycat version) is a pharmaceutical product that is close, but not identical, copy of an approved biologic branded product. It is known as a biosimilar, rather than a biogeneric, because current technology does not approve of making an exact copy of a large molecule drug and the sky reaching cost of pharmaceuticals, especially biologics seeks the concern to control the healthcare costs. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to the approved biologic product, known as a reference product. Biosimilar are not generic alternatives of innovator drugs nor can they be the exact duplicates of...